Twist Bioscience Corp president Patrick John Finn sells $347,306 in shares
After the sale, the filing lists 180,278 shares held. Information only, not investment advice.
Patrick John Finn sold about $350,000 of Twist Bioscience Corp (TWST) stock on Nov 3, according to an SEC filing. The president received an average of $135.40 for 2,565 shares.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. After the trade, the filing lists 180,278 shares held.
Five Twist Bioscience Corp insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Twist Bioscience Corp (TWST) |
|---|---|
| Insider | Patrick John Finn |
| Role | President |
| Transaction | Open-market sale (code S) |
| Shares | 2,565 |
| Average price | $135.40 |
| Value | $347,306 |
| Trade date | Nov 3, 2026 |
| Filed with the SEC | Nov 5, 2026, 4:05 PM ET |
| Shares held after | 180,278 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this TWST sale
Read the daily insider trading roundup · Follow TWST for the next insider trade
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Twist Bioscience Corp CEO Emily M. Leproust sells $619,193 of TWST
- Insider Trading News
Five insiders sell Twist Bioscience Corp shares, $1.55M in total
- Insider Trading News
Twist Bioscience Corp SVP of human resources Paula Green trims stake with $136,350 sale
- Insider Trading News
Twist Bioscience Corp officer Dennis Cho sells 949 shares worth $128,497
- Stock Markets News
Why is Twist Bioscience stock sliding today?